litlas
Log inCreate account

Vincent T. DeVita

Active 1966–2016

Also published as
VINCENT T. DeVITA · VINCENT T. DEVITA
76
Papers
18,370
Citations
76
h-index
76
i10-index

Citations

Citations per year for Vincent T. DeVita1968: 2 citations1969: 3 citations1970: 6 citations1971: 6 citations1972: 26 citations1973: 33 citations1974: 35 citations1975: 50 citations1976: 52 citations1977: 51 citations1978: 57 citations1979: 53 citations1980: 85 citations1981: 74 citations1982: 96 citations1983: 85 citations1984: 81 citations1985: 79 citations1986: 69 citations1987: 78 citations1988: 86 citations1989: 79 citations1990: 73 citations1991: 99 citations1992: 71 citations1993: 69 citations1994: 88 citations1995: 60 citations1996: 60 citations1997: 72 citations1998: 57 citations1999: 65 citations2000: 65 citations2001: 50 citations2002: 69 citations2003: 67 citations2004: 44 citations2005: 51 citations2006: 29 citations2007: 44 citations2008: 48 citations2009: 42 citations2010: 36 citations2011: 40 citations2012: 35 citations2013: 49 citations2014: 55 citations2015: 45 citations2016: 40 citations2017: 51 citations2018: 54 citations2019: 142 citations2020: 151 citations2021: 134 citations2022: 111 citations2023: 94 citations2024: 108 citations2025: 48 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,498 citing papers, 39.9% of this breakdownUnited Kingdom: 240 citing papers, 6.4% of this breakdownChina: 187 citing papers, 5% of this breakdownGermany: 178 citing papers, 4.7% of this breakdownItaly: 163 citing papers, 4.3% of this breakdownCanada: 154 citing papers, 4.1% of this breakdownFrance: 124 citing papers, 3.3% of this breakdownIndia: 112 citing papers, 3% of this breakdownNetherlands: 97 citing papers, 2.6% of this breakdownAustralia: 81 citing papers, 2.1% of this breakdownJapan: 61 citing papers, 1.6% of this breakdownSpain: 60 citing papers, 1.6% of this breakdown
0%39.9%Other 21.4%

Institutions

Fields

  • Medicine70%
  • Biochemistry, Genetics and Molecular Biology13.9%
  • Immunology and Microbiology5.2%
  • Materials Science2.3%
  • Engineering1.9%
  • Computer Science1.2%
  • Other5.5%

Topics

  • Lymphoma Diagnosis and Treatment8.1%
  • Viral-associated cancers and disorders2.5%
  • Chronic Lymphocytic Leukemia Research2.4%
  • CNS Lymphoma Diagnosis and Treatment2.2%
  • Antifungal resistance and susceptibility1.9%
  • Lung Cancer Treatments and Mutations1.7%
  • Other81.2%

Coauthors

All papers

Open in search
  1. A History of Cancer Chemotherapy

    Authors: Vincent T. DeVita, Edward Chu - Cancer Research 2008 cited by 1,943

  2. Two Hundred Years of Cancer Research

    Authors: Vincent T. DeVita, Steven A. Rosenberg - New England Journal of Medicine 2012 cited by 312

  3. DeVita, Hellman, and Rosenberg's cancer : principles & practice of oncology

    Authors: Vincent T. DeVita, Theodore S. Lawrence, Steven A. Rosenberg - 2011 cited by 539

  4. Curability of Advanced Hodgkin's Disease with Chemotherapy

    Authors: Vincent T. DeVita, RICHARD M. SIMON, SUSAN M. HUBBARD, ROBERT C. YOUNG, COSTAN W. BERARD, JOHN H. MOXLEY, EMIL FREI, PAUL P. CARBONE, GEORGE P. CANELLOS - Annals of Internal Medicine 1980 cited by 474

  5. Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

    Authors: Vincent T. DeVita, ARTHUR A. SERPICK, PAUL P. CARBONE - Annals of Internal Medicine 1970 cited by 1,447

  6. Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer

    Authors: Vincent T. DeVita, Robert C. Young, George P. Canellos - Cancer 1975 cited by 413

  7. A Phase I–II Trial of Multiple-Dose Polyriboinosinic-Polyribocytidylic Acid in Patients With Leukemia or Solid Tumors

    Authors: R. A. H. ROBINSON, Vincent T. DeVita, Hilton B. Levy, Samuel Baron, Susan P. Hubbard, Arthur S. Levine - JNCI Journal of the National Cancer Institute 1976 cited by 187

  8. Report of the Committee on Hodgkin's Disease Staging Procedures.

    Authors: Saul A. Rosenberg, M Boiron, Vincent T. DeVita, Ralph E. Johnson, Burton J. Lee, John E. Ultmann, Manuel Viamonte - 1971 cited by 207

  9. Treatment of Hodgkin Lymphoma: A 50-Year Perspective

    Authors: George P. Canellos, Saul A. Rosenberg, Jonathan W. Friedberg, Tim Lister, Vincent T. DeVita - Journal of Clinical Oncology 2014 cited by 157

  10. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.

    Authors: Dan L. Longo, P L Duffey, Robert C. Young, S M Hubbard, Daniel C. Ihde, Eli Glatstein, John C. Phares, Elaine S. Jaffe, Walter J. Urba, Vincent T. DeVita - Journal of Clinical Oncology 1992 cited by 376

  11. Clinical pharmacology of cyclophosphamide.

    Authors: Charles M. Bagley, Frieda Bostick, Vincent T. DeVita - 1973 cited by 315

  12. Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides)

    Authors: William C. Roberts, D. Luke Glancy, Vincent T. DeVita - The American Journal of Cardiology 1968 cited by 315

  13. Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally.

    Authors: James L. Speyer, Jerry M. Collins, Robert L. Dedrick, Murray F. Brennan, Alan R. Buckpitt, Harold Londer, Vincent T. DeVita, Charles E. Myers - 1980 cited by 252

  14. Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.

    Authors: Daniele Longo, Vincent T. DeVita, P L Duffey, Margaret N. Wesley, Daniel C. Ihde, S M Hubbard, M Gilliom, Elaine S. Jaffe, Jeffrey Cossman, Richard I. Fisher - Journal of Clinical Oncology 1991 cited by 219

  15. Current results of the screening program at the division of cancer treatment, national cancer institute

    Authors: Abraham Goldin, John M. Venditti, John S. Macdonald, Franco M. Muggia, Jane E. Henney, Vincent T. DeVita - European Journal of Cancer (1965) 1981 cited by 208

  16. Clinical antitumor activity and toxicity of streptozotocin (NSC-85998)

    Authors: P. Schein, M J O'Connell, Johannes Blom, S M Hubbard, I T Magrath, Patrick R. Bergevin, Peter H. Wiernik, J. L. Ziegler, Vincent T. DeVita - Cancer 1974 cited by 190

  17. The physiological disposition of the carcinostatic 1,3‐bis(2‐chloroethyU‐l‐nitrosourea (BCNU) in man and animals

    Authors: Vincent T. DeVita, Charlene Denham, Jack D. Davidson, Vincent T. Oliverio - Clinical Pharmacology & Therapeutics 1967 cited by 103

  18. Physician's cancer chemotherapy drug manual 2008

    Authors: Edward Chu, Vincent T. DeVita, Devita - Medical Entomology and Zoology 2003 cited by 102

  19. Intensive Combination Chemotherapy and X-Irradiation in Hodgkin's Disease

    Authors: Vincent T. DeVita, Elizabeth DeVita-Raeburn, John H. Moxley - Cancer Research 2016 cited by 81

  20. THE SPECTRUM OF THE DISEASE IN 98 PATIENTS

    Authors: Robert C. Young, John E. Bennett, Charles L. Vogel, Paul P. Carbone, Vincent T. DeVita - Medicine 1970 cited by 988

  21. Important Advances in Oncology

    Authors: Vincent T. DeVita, S Hellman, S A Rosenberg - Anti-Cancer Drugs 1991 cited by 762

  22. Twenty years of MOPP therapy for Hodgkin's disease.

    Authors: Dan L. Longo, Robert C. Young, Margaret Wesley, S M Hubbard, P L Duffey, Elaine S. Jaffe, Vincent T. DeVita - Journal of Clinical Oncology 1986 cited by 439

  23. Diffuse Aggressive Lymphomas: Increased Survival After Alternating Flexible Sequences of ProMACE and MOPP Chemotherapy

    Authors: Richard I. Fisher, VINCENT T. DeVITA, SUSAN M. HUBBARD, DAN L. LONGO, ROBERT WESLEY, BRUCE A. CHABNER, ROBERT C. YOUNG - Annals of Internal Medicine 1983 cited by 378

  24. Bleomycin, Adriamycin, Cyclophosphamide, Vincristine, and Prednisone (BACOP) Combination Chemotherapy in the Treatment of Advanced Diffuse Histiocytic Lymphoma

    Authors: Philip S. Schein, VINCENT T. DeVITA, SUSAN HUBBARD, BRUCE A. CHABNER, GEORGE P. CANELLOS, COSTAN BERARD, ROBERT C. YOUNG - Annals of Internal Medicine 1976 cited by 346